Lehrstuhl für Strahlentherapie

Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) Rudolf J, Büttner-Herold M, Erlenbach-Wuensch K, Posselt R, Jeßberger J, Haderlein M, Hecht M, et al. Journal article Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients (2020) Böckelmann F, Putz F, Kallis K, Lettmaier S, Fietkau R, Bert C Journal article Erste erfolgversprechende Ergebnisse der Kombination aus Strahlentherapie und Pembrolizumab beim metastasierten nichtkleinzelligen Lungenkarzinom (2020) Hecht M, Gaipl U, Fietkau R Journal article Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review (2020) Krug D, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, et al. Journal article Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay (2020) Donaubauer AJ, Becker I, Rühle PF, Fietkau R, Gaipl U, Frey B Book chapter / Article in edited volumes On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data (2020) Witulla B, Goerig N, Putz F, Frey B, Engelhorn T, Dörfler A, Uder M, et al. Journal article An Investigation of Feature-based Nonrigid Image Registration using Gaussian Process (2020) Bayer S, Spiske U, Geimer T, Luo J, Wells III WM, Ostermeier M, Fahrig R, et al. Conference contribution Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020) Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al. Journal article Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? (2019) Mayo T, Haderlein M, Schuster B, Wiesmueller A, Hummel C, Bachl M, Schmidt M, et al. Journal article Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12 (2019) Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, et al. Journal article